Tag: Ulcerative Colitis

Mirikizumab Demonstrates Superiority over Placebo in Phase 3 Maintenance Study in Ulcerative Colitis, Supporting Regulatory Submissions in 2022
February 2022 • Volume XLVI, Issue 2
Mirikizumab Up-regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for up to One Year in Phase 2 Study
July 2021 • Volume XLV, Issue 7
Lilly’s Mirikizumab Helps Patients Achieve Clinical Remission and Improves Symptoms in Adults with Ulcerative Colitis in 12-week Phase 3 Induction Study
April 2021 • Volume XLV, Issue 4
Ulcerative Colitis in the Elderly: Indications and Outcomes of Ileal Pouch-Anal Anastomosis (IPAA)
February 2021 • Volume XLV, Issue 2
High Output Ileostomies: The Stakes are Higher than the Output
September 2019 • Volume XLIII, Issue 9
Achieving Clinical Remission and Mucosal Healing in Patients with Active Ulcerative Colitis
April 2019 • Volume XLIII, Issue 4
The IBD Therapeutic Pipeline Is Primed to Produce
April 2019 • Volume XLIII, Issue 4
Managing Severe Ulcerative Colitis in the Hospitalized Patient
October 2018 • Volume XLII, Issue 10
Inflammatory Bowel Disease in the Older Patient
May 2018 • Volume XLII, Issue 5
The Microbiome and Inflammatory Bowel Disease
January 2018 • Volume XLII, Issue 1